Forecasting Trachoma Control
Forecasting Trachoma Control
批准号:
10587368
负责人:
THOMAS M LIETMAN
金额:
$40.38万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
未结题
起止时间:
2016-06-01 至 2028-05-31
关键词:
AccelerationAgreementAntibioticsAreaAzithromycinBackCertificationChildChlamydia InfectionsChlamydia trachomatisClinicalClinical TrialsCollaborationsCountryDataDiseaseDoseGoalsGrantGuidelinesHealthHot SpotHygieneInfectionInterventionMethodsMicrobiologyModelingOralPolicy MakerPrevalencePublic HealthRecommendationResearchSamplingSanitationSerologySourceStatistical MethodsSurveillance MethodsSurveysTechniquesTimeTrachomaUpdateWaterWorld Healthchronic infectionimprovedmathematical modeloptimal treatmentsprogramssuccesssurveillance strategytheoriestransmission process
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
Trachoma programs have been enormously successful, but they fell short of their goal of Global
Elimination of Trachoma by 2020. Nearly one third of endemic districts still had not met the threshold for control.
Why?
One reason may be that the 2020 goals were set long before sufficient evidence was available. In the
original grant period, we used program surveys to forecast the distribution of active trachoma worldwide. We
also used NEI clinical trial data to better define the relationship between clinical activity and actual chlamydial
infection. New clinical, infection, and serology data will now enable more precise estimates. In carrying out the
aims of this current proposal, we will use these enriched information sources to forecast which districts will
achieve control under current efforts.
A second factor is that the trachoma intervention guidelines have essentially been “one size fits all”. Here,
we propose to assess the enhanced interventions necessary to achieve control in hotspots where current efforts
are not sufficient for trachoma control.
Finally, the WHO plan acknowledged that resurgence may happen. In the original grant period, we
demonstrated that surveys of trachoma prevalence sometimes switched from supporting control to questioning
control. In this current proposal we propose to model resurgence so that surveillance of resurgence can be
improved.
In summary, we propose: (a) real-time open-access forecasts that set realistic interim and elimination
goals to help keep our specific collaborating stakeholder's programs on track; (b) models for better targeting hot
spots with enhanced interventions to accelerate success; (c) models for rational surveillance for resurgence to
maintain control once success has been declared.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Azithromycin Reduction to Reach Elimination of Trachoma
-
批准号:10439385
-
项目类别:
-
资助金额:$5.08万
-
财政年份:2020
-
负责人:THOMAS M LIETMAN
-
依托单位:
Azithromycin Reduction to Reach Elimination of Trachoma
-
批准号:10616840
-
项目类别:
-
资助金额:$7.34万
-
财政年份:2020
-
负责人:THOMAS M LIETMAN
-
依托单位:
Azithromycin Reduction to Reach Elimination of Trachoma
-
批准号:10397057
-
项目类别:
-
资助金额:$76.63万
-
财政年份:2020
-
负责人:THOMAS M LIETMAN
-
依托单位:
UCSF-Proctor Clinician Vision Scholars K12 Program
-
批准号:10610924
-
项目类别:
-
资助金额:$53.14万
-
财政年份:2020
-
负责人:THOMAS M LIETMAN
-
依托单位:
UCSF-Proctor Clinician Vision Scholars K12 Program
-
批准号:10409646
-
项目类别:
-
资助金额:$53.14万
-
财政年份:2020
-
负责人:THOMAS M LIETMAN
-
依托单位:
Azithromycin Reduction to Reach Elimination of Trachoma
-
批准号:10907941
-
项目类别:
-
资助金额:$2.6万
-
财政年份:2020
-
负责人:THOMAS M LIETMAN
-
依托单位:
Azithromycin Reduction to Reach Elimination of Trachoma
-
批准号:10618166
-
项目类别:
-
资助金额:$79.31万
-
财政年份:2020
-
负责人:THOMAS M LIETMAN
-
依托单位:
Steroids and Cross-linking for Ulcer Treatment (SCUT II)
-
批准号:10397960
-
项目类别:
-
资助金额:$1.3万
-
财政年份:2019
-
负责人:THOMAS M LIETMAN
-
依托单位:
Steroids and Cross-linking for Ulcer Treatment (SCUT II)
-
批准号:10457913
-
项目类别:
-
资助金额:$79.62万
-
财政年份:2019
-
负责人:THOMAS M LIETMAN
-
依托单位:
Steroids and Cross-linking for Ulcer Treatment (SCUT II)
-
批准号:10222699
-
项目类别:
-
资助金额:$86.37万
-
财政年份:2019
-
负责人:THOMAS M LIETMAN
-
依托单位:
Steroids and Cross-linking for Ulcer Treatment (SCUT II)
-
批准号:10666415
-
项目类别:
-
资助金额:$74.59万
-
财政年份:2019
-
负责人:THOMAS M LIETMAN
-
依托单位:
Steroids and Cross-linking for Ulcer Treatment (SCUT II)
-
批准号:10167111
-
项目类别:
-
资助金额:$8.71万
-
财政年份:2019
-
负责人:THOMAS M LIETMAN
-
依托单位:
Kebele Elimination of Trachoma for Ocular Health
-
批准号:9752569
-
项目类别:
-
资助金额:$60.55万
-
财政年份:2017
-
负责人:THOMAS M LIETMAN
-
依托单位:
Kebele Elimination of Trachoma for Ocular Health
-
批准号:10441068
-
项目类别:
-
资助金额:$84.29万
-
财政年份:2017
-
负责人:THOMAS M LIETMAN
-
依托单位:
Kebele Elimination of Trachoma for Ocular Health
-
批准号:9965928
-
项目类别:
-
资助金额:$62.62万
-
财政年份:2017
-
负责人:THOMAS M LIETMAN
-
依托单位:
Forecasting Trachoma Control
-
批准号:9107191
-
项目类别:
-
资助金额:$39.94万
-
财政年份:2016
-
负责人:THOMAS M LIETMAN
-
依托单位:
Digital Detection of Infectious Eye Epidemics
-
批准号:9030980
-
项目类别:
-
资助金额:$39.42万
-
财政年份:2016
-
负责人:THOMAS M LIETMAN
-
依托单位:
Digital Detection of Infectious Eye Epidemics
-
批准号:9207459
-
项目类别:
-
资助金额:$37.6万
-
财政年份:2016
-
负责人:THOMAS M LIETMAN
-
依托单位:
Forecasting Trachoma Control
-
批准号:9267470
-
项目类别:
-
资助金额:$39.94万
-
财政年份:2016
-
负责人:THOMAS M LIETMAN
-
依托单位:
Forecasting Trachoma Control
-
批准号:9479209
-
项目类别:
-
资助金额:$39.65万
-
财政年份:2016
-
负责人:THOMAS M LIETMAN
-
依托单位:
海外基金